Potential Function of miRNAs in Herpetic Stromal Keratitis
Authors:
- 1 January 2013
- journal article
- review article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 54 (1) , 563-573
Abstract
MicroRNAs (miRNAs), the newly discovered regulators of gene expression, act by promoting degradation of mRNA and/or by inhibiting protein expression. Dysregulation of miRNA expression has been noted in an expanding number of diseases; and in some instances, manipulating miRNA expression holds promise as a new form of therapy. Herpetic stromal keratitis (HSK) is an important vision-impairing lesion and currently any role that miRNA dysregulation plays during its pathogenesis is only just beginning to be investigated. In this review, we discuss the likely participation of specific miRNAs during HSK and discuss the prospect of modulating their expression as a means of therapy.Keywords
This publication has 97 references indexed in Scilit:
- Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAsThe American Journal of Pathology, 2012
- Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal gangliaVirology, 2011
- Silencing of microRNA‐21 in vivo ameliorates autoimmune splenomegaly in lupus miceEMBO Molecular Medicine, 2011
- Alternative miRNA Biogenesis Pathways and the Interpretation of Core miRNA Pathway MutantsMolecular Cell, 2011
- MicroRNA-29 Regulates T-Box Transcription Factors and Interferon-γ Production in Helper T CellsImmunity, 2011
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell DevelopmentImmunity, 2010
- Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 ResponsesCell, 2010
- MicroRNA‐mediated gene silencing modulates the UV‐induced DNA‐damage responseThe EMBO Journal, 2009
- Foxp3-Dependent MicroRNA155 Confers Competitive Fitness to Regulatory T Cells by Targeting SOCS1 ProteinImmunity, 2009
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005